Alcon Inc.

Alcon Inc.

ALC

$65.39

Updated: 24/09/2026, 07:31:16

Market Cap
$31.89B
Sector
Healthcare
Industry
Medical - Specialties
Country
CH
Stock valuation chart
One-year closing share-price history for ALC
Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

USD
NYSE
CEO: David J. Endicott
Employees: 25,000
https://www.alcon.com
Asset Summaries
Latest generated summaries for ALC

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ALC.
Share price
$65.39
Market cap
$31.89B
Exchange
NYSE
Currency
USD
CEO
David J. Endicott
Employees
25,000
IPO date
09/04/2019
Beta
0.698
Last dividend
$0.00
Day range
$65.06 – $65.71
52-week range
$61.84 – $87.64
1-day performance
-0.30%
1-year performance
5.75%
Current drawdown (1Y)
-25.39%
CIK
0001167379
CUSIP
H01301128
ISIN
CH0432492467
Created
07/12/2025, 02:01:24
Last update
24/09/2026, 07:31:16

Track Alcon Inc. with an AI analyst

See which prediction-market events move ALC, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to ALC from your Railway `news_articles` table.